Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Herb: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final ingredient record.
- Ingredient Id
- 36223
- Core Entity Id
- 43455
- Source Entity Count
- 1
- Preferred Name
- Ustiloxin
- Name En
- Pubchem Id
- 9552083
- Smiles Canonical
- CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2S(=O)CC(CC(C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C
- Molecular Formula
- C28H43N5O12S
- Molecular Weight
- 673.7420
- Inchikey
- QRLBQXQEGMBXFM-JHIHKWCFSA-N
- Inchi
- InChI=1S/C28H43N5O12S/c1-6-28(4)23(26(41)31-10-19(36)37)33-24(39)20(12(2)3)32-25(40)21(30-5)22(38)14-8-17(45-28)16(35)9-18(14)46(44)11-13(34)7-15(29)27(42)43/h8-9,12-13,15,20-23,30,34-35,38H,6-7,10-11,29H2,1-5H3,(H,31,41)(H,32,40)(H,33,39)(H,36,37)(H,42,43)/t13-,15-,20-,21-,22+,23+,28+,46+/m0/s1
- Isomeric Smiles
- CC[C@@]1([C@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](C2=CC(=C(C=C2[S@](=O)C[C@H](C[C@@H](C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C
- Cas Id
- Ob Score
- Mol Logp
- -2.3284
- Num H Donors
- 10
- Num H Acceptors
- 12
- Num Rotatable Bonds
- 12
- Drug Likeness
- 0.1110
- Polar Surface Area
- Molecular Volume
- Alogp
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Ustiloxin
Role
preferred
Source
HERB_v2
Preferred
Yes
Name
Ustiloxin
Role
preferred
Source
itcmdb_public
Preferred
Yes
Name
ustiloxin
Role
preferred
Source
TCMBank
Preferred
Yes
Name
(2S,4S)-2-amino-5-((R)-((2R,3S,6S,9S,10R)-9-(carboxymethylcarbamoyl)-10-ethyl-2,13-dihydroxy-6-isopropyl-10-methyl-3-(methylamino)-4,7-dioxo-11-oxa-5,8-diazabicyclo(10.3.1)hexadeca-1(16),12,14-trien-15-yl)sulfinyl)-4-hydroxy-pentanoic acid
Role
alias
Source
itcmdb_public
Preferred
No
Name
(2S,4S)-2-amino-5-((R)-((3R,4S,7S,10S,11R)-4-(carboxymethylcarbamoyl)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-propan-2-yl-2-oxa-5,8-diazabicyclo(10.3.1)hexadeca-1(15),12(16),13-trien-13-yl)sulfinyl)-4-hydroxypentanoic acid
Role
alias
Source
itcmdb_public
Preferred
No
Name
(2S,4S)-2-amino-5-[(R)-[(2R,3S,6S,9S,10R)-9-(carboxymethylcarbamoyl)-10-ethyl-2,13-dihydroxy-6-isopropyl-10-methyl-3-(methylamino)-4,7-dioxo-11-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-15-yl]sulfinyl]-4-hydroxy-pentanoic acid
Role
alias
Source
HERB_v2
Preferred
No
Name
(2S,4S)-2-amino-5-[(R)-[(3R,4S,7S,10S,11R)-4-(carboxymethylcarbamoyl)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-propan-2-yl-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(15),12(16),13-trien-13-yl]sulfinyl]-4-hydroxypentanoic acid
Role
alias
Source
HERB_v2
Preferred
No
Name
5-[4-{[(Carboxymethyl)imino](hydroxy)methyl}-3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaene-13-sulfinyl]-4-hydroxynorvaline
Role
alias
Source
itcmdb_public
Preferred
No
Name
5-[4-{[(Carboxymethyl)imino](hydroxy)methyl}-3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaene-13-sulfinyl]-4-hydroxynorvaline
Role
alias
Source
HERB_v2
Preferred
No
Name
C08442
Role
alias
Source
HERB_v2
Preferred
No
Name
C08442
Role
alias
Source
itcmdb_public
Preferred
No
Name
CHEBI:9914
Role
alias
Source
itcmdb_public
Preferred
No
Name
CHEBI:9914
Role
alias
Source
HERB_v2
Preferred
No
Name
DTXSID40931945
Role
alias
Source
itcmdb_public
Preferred
No
Name
DTXSID40931945
Role
alias
Source
HERB_v2
Preferred
No
Name
Q27108516
Role
alias
Source
itcmdb_public
Preferred
No
Name
Q27108516
Role
alias
Source
HERB_v2
Preferred
No
Aliases
Additional names normalized into the restored final schema.
(2S,4S)-2-amino-5-((R)-((2R,3S,6S,9S,10R)-9-(carboxymethylcarbamoyl)-10-ethyl-2,13-dihydroxy-6-isopropyl-10-methyl-3-(methylamino)-4,7-dioxo-11-oxa-5,8-diazabicyclo(10.3.1)hexadeca-1(16),12,14-trien-15-yl)sulfinyl)-4-hydroxy-pentanoic acid(2S,4S)-2-amino-5-((R)-((3R,4S,7S,10S,11R)-4-(carboxymethylcarbamoyl)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-propan-2-yl-2-oxa-5,8-diazabicyclo(10.3.1)hexadeca-1(15),12(16),13-trien-13-yl)sulfinyl)-4-hydroxypentanoic acid(2S,4S)-2-amino-5-[(R)-[(2R,3S,6S,9S,10R)-9-(carboxymethylcarbamoyl)-10-ethyl-2,13-dihydroxy-6-isopropyl-10-methyl-3-(methylamino)-4,7-dioxo-11-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-15-yl]sulfinyl]-4-hydroxy-pentanoic acid(2S,4S)-2-amino-5-[(R)-[(3R,4S,7S,10S,11R)-4-(carboxymethylcarbamoyl)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-propan-2-yl-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(15),12(16),13-trien-13-yl]sulfinyl]-4-hydroxypentanoic acid5-[4-{[(Carboxymethyl)imino](hydroxy)methyl}-3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaene-13-sulfinyl]-4-hydroxynorvalineC08442CHEBI:9914DTXSID40931945Q27108516
Cross References
Trusted external identifiers retained for this final record.
Herb
HBIN047644
Npass
NPC27574
Tcmid
22268
Pub Chem
9552083
Tcmbank
TCMBANKIN049533
Attributes
Merged source attributes and domain-specific metadata.
In Ch I
InChI=1S/C28H43N5O12S/c1-6-28(4)23(26(41)31-10-19(36)37)33-24(39)20(12(2)3)32-25(40)21(30-5)22(38)14-8-17(45-28)16(35)9-18(14)46(44)11-13(34)7-15(29)27(42)43/h8-9,12-13,15,20-23,30,34-35,38H,6-7,10-11,29H2,1-5H3,(H,31,41)(H,32,40)(H,33,39)(H,36,37)(H,42,43)/t13-,15-,20-,21-,22+,23+,28+,46+/m0/s1
Mol Wt
673.7420000000001
Smiles
CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2S(=O)CC(CC(C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C
Mol Log P
-2.32839999999999
In Ch Ikey
QRLBQXQEGMBXFM-JHIHKWCFSA-N
Mol2 Path
/TCM_database/2007_3d_all/22284.mol2
Reference
660
Num Hdonors
10
Drug Likeness
0.111
Num Hacceptors
12
Isomeric Smiles
CC[C@@]1([C@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](C2=CC(=C(C=C2[S@](=O)C[C@H](C[C@@H](C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C
Canonical Smiles
CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2S(=O)CC(CC(C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C
Herb Alias Names
C08442(2S,4S)-2-amino-5-[(R)-[(3R,4S,7S,10S,11R)-4-(carboxymethylcarbamoyl)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-propan-2-yl-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(15),12(16),13-trien-13-yl]sulfinyl]-4-hydroxypentanoic acid(2S,4S)-2-amino-5-[(R)-[(2R,3S,6S,9S,10R)-9-(carboxymethylcarbamoyl)-10-ethyl-2,13-dihydroxy-6-isopropyl-10-methyl-3-(methylamino)-4,7-dioxo-11-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-trien-15-yl]sulfinyl]-4-hydroxy-pentanoic acid(2S,4S)-2-amino-5-((R)-((2R,3S,6S,9S,10R)-9-(carboxymethylcarbamoyl)-10-ethyl-2,13-dihydroxy-6-isopropyl-10-methyl-3-(methylamino)-4,7-dioxo-11-oxa-5,8-diazabicyclo(10.3.1)hexadeca-1(16),12,14-trien-15-yl)sulfinyl)-4-hydroxy-pentanoic acid(2S,4S)-2-amino-5-((R)-((3R,4S,7S,10S,11R)-4-(carboxymethylcarbamoyl)-3-ethyl-11,15-dihydroxy-3-methyl-10-(methylamino)-6,9-dioxo-7-propan-2-yl-2-oxa-5,8-diazabicyclo(10.3.1)hexadeca-1(15),12(16),13-trien-13-yl)sulfinyl)-4-hydroxypentanoic acidCHEBI:9914DTXSID40931945Q271085165-[4-{[(Carboxymethyl)imino](hydroxy)methyl}-3-ethyl-6,9,11,15-tetrahydroxy-3-methyl-10-(methylamino)-7-(propan-2-yl)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaene-13-sulfinyl]-4-hydroxynorvaline
Molecular Weight
673.7 g/mol
Molecular Formula
C28H43N5O12S
Molecular Formula
C28H43N5O12S
Num Rotatable Bonds
12